Unclaimed brand
Disruptive Pharma is a Swedish pharmaceutical technology company developing Formulite®, a patented and clinically evaluated bioavailability platform designed to improve the performance of oral drug products. The company is listed on Nasdaq First North Growth Market Stockholm. Formulite® addresses challenges related to poor solubility, limited oral bioavailability and other formulation-related properties that may affect dosing, patient adherence, manufacturing and the commercial potential of a drug product. The aim is to contribute to the development of new and improved drug products. Disruptive Pharma’s core strategy is to commercialize Formulite® through partnerships, development projects and licensing agreements with pharmaceutical and biotechnology companies. In parallel, the company is establishing strategic collaborations with contract development and manufacturing organizations, CDMOs, to enable broader industrial use of Formulite®. In 2025, the first clinical study of a Formulite®-based formulation was completed. The study generated clinical data on safety and tolerability and represents an important validation of the platform in humans.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#F0915D
Sandy brown
240, 145, 93
21, 83, 65
0, 40, 61, 6
#FCFCFD
Athens Gray
252, 252, 253
240, 20, 99
0, 0, 0, 1
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Disruptive Pharma AB is a pharmaceutical technology company developing and commercializing Formulite®, its patented platform for amorphous drug development. The technology is designed to improve the solubility and oral bioavailability of pharmaceutical compounds, along with other properties that can support their performance. The company presents Formulite® as a way to enhance bioavailability, optimize pill size and enable more environmentally friendly manufacturing.
Disruptive Pharma’s work spans the development, manufacturing and performance validation of its platform, and the company invites partners to explore collaboration opportunities. Its website provides information about how Formulite® works, its manufacturing approach and validation, as well as the company’s leadership, board, investors and corporate governance. The company is based in Uppsala, Sweden, with a facility at Uppsala Science Park, and has a registered address in Stockholm. Its newsroom shares press releases, news, events and presentations. Through its platform and partnering activities, Disruptive Pharma focuses on applying pharmaceutical technology to address challenges in drug formulation and oral delivery.
Company type
Privately Held
Year founded
2021
Company size
11-50 employees
How do I download the Disruptive Pharma logo?
The Disruptive Pharma logo comes in two versions: dark icon and light logo. Download as transparent PNG or JPEG.
What are Disruptive Pharma's brand colors?
The Disruptive Pharma color palette uses the hex codes #F0915D, #FCFCFD and #000000.
The Disruptive Pharma name, logos and brand assets are trademarks of Disruptive Pharma and its affiliates. Brandfetch isn't affiliated with or endorsed by Disruptive Pharma. Their use is subject to Disruptive Pharma's brand guidelines.
